health centers and clinics across Washington are offering free asthma inhalers to uninsured and underserved asthma patient
http://www.healasthma.com
|
|
http://www.healasthma.com past six monthsthe past twelve months Search Hint Connecting terms with OR broadens your search to give more results …more on search operators – . New ‘green’ version is mandated, costs more Health risk ‘It’s possible people skimp on their medicine because of the cost. Clearly that would not be a good strategy because you might end up in the emergency room.’ Dr. Bradley Becker, Cardinal Glennon With the year drawing near, people who suffer from asthma and other respiratory ailments only have a few days before the last of the inhalers that use an ozone-depeleting chemical disappear from pharmacy shelves and are replaced with new “green” devices.Because the new devices are more expensive, the switch has raised the possibility of last-minute hoarding. It also has triggered concerns that the added expense of the new inhalers – which could cost an extra… . EDGAR Online -K Glimpse (USA) – -K MEDCO HEALTH SOLUTIONS INC ——————————————————————————– UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. ——————————————————————————– FORM -K ——————————————————————————– CURRENT REPORT Pursuant to Section or (d) of the Securities Exchange Act of Date of Report (Date of earliest event reported) … . FREE FOR SOME PATIENTS More than community health centers and clinics across Washington are offering free asthma inhalers to uninsured and underserved asthma patients. A federal ban on chlorofluorocarbons requires all asthma patients who use Albuterol inhalers to switch to an environmentally friendly inhaler by Dec. , . The ASPIRE Campaign targets clinics and health centers with the most need for asthma inhalers to make it easier for low-income patients to make the transition sooner. Participating… FDA approves Mylan’s asthma treatment CANONSBURG – Southpointe-based Mylan Laboratories Inc. said Tuesday it has received final approval from the U.S. Food and Drug Administration to market extended-release albuterol sulfate tablets.The drug is a bronchodilator approved to treat spasms from obstructive respiratory diseases like asthma, chronic bronchitis, and other chronic obstructive pulmonary diseases.The tablets, which will be available in -milligram and FDA approves Mylan’s asthma treatment CANONSBURG – Southpointe-based Mylan Laboratories Inc. said Tuesday it has received final approval from the U.S. Food and Drug Administration to market extended-release albuterol sulfate tablets.The drug is a bronchodilator approved to treat spasms from obstructive respiratory diseases like asthma, chronic bronchitis, and other chronic obstructive pulmonary diseases.The tablets, which will be available in -milligram and… . Montgomery Advertiser HOW IS RSV TREATED? There is no specific treatment for RSV, said Dr. Allen White, a Montgomery pediatrician. But doctors can provide supportive treatment. Some babies respond favorably to common asthma treatments such as Xopenex or Albuterol, dispersed through a nebulizer that sends out the medicines in a mist, or put in a mask so the baby can breathe it in. Children who are hospitalized with RSV are placed in tents to help them take in more oxygen than they would be able to inhale on their own. But most children… . FD (FAIR DISCLOSURE) WIRE – Event Brief of Q Ivax Earnings Conference Call – Final CORPORATE PARTICIPANTS . Dr. Phillip Frost, IVAX Corporation, Chairman & CEO . David Malina, IVAX Corporation, Director – IR . Neil Flanzraich, IVAX Corporation, Vice Chairman & President . Tom Beier, IVAX Corporation, SVP Finance & CFO OVERVIEW IVX reported net revenues of . m and EPS of . in Q . On / / IVX acquired Phoenix Scientific, the US’ leading manufacturer of generic veterinary pharmaceutical products…. . FD (FAIR DISCLOSURE) WIRE – Q Ivax Earnings Conference Call – Final OPERATOR Welcome to the IVAX Corporation second quarter earnings call. (OPERATOR INSTRUCTIONS). As a reminder, today’s call is being recorded. I would now like to turn the conference over to Dr. Phillip Frost. Please go ahead. PHILLIP FROST, CHAIRMAN, CEO, IVAX CORPORATION Good morning everyone. I am Phillip Frost, Chairman and CEO of IVAX Corporation. And I would like to welcome you to our conference call and webcast to discuss our Company’s second… . Uninsured’s ills worsen come bills To read Scott Ferguson’s hospital bill is to know the insanity of modern medical economics and the nightmare of million Americans without health insurance. Here is an albuterol inhaler available at drugstore.com for . . Centura Health’s St. Anthony Central Hospital in Denver charged Ferguson . . Here is a -cent dose of the diuretic Lasix. Centura wanted Ferguson to pay . . Ferguson, a -year-old musician with a heart… . Los Angeles Times – HEALTH Settlement Reached in Inhaler Lawsuit Copley Pharmaceutical Inc. agreed to pay up to million to settle the suits alleging that bacterial contamination of its respiratory drug albuterol caused sickness and death. The tentative settlement announced by U.S. District Judge Clarence Brimmer halted a -day-old trial on consolidated lawsuits filed over deaths and injuries nationwide. Albuterol is used by asthmatics and others with breathing disorders and is often taken through aeros… . , The ASTHMA DRUG RECALLED A Massachusetts generic drug company said Wednesday it is recalling millions of vials of an inhalation solution widely used by asthma patients.Copley Pharmaceutical Inc. said some of its -milliliter Albuterol Sulfate Inhalation Solution was contaminated by microbial organisms.It poses special risks of serious infection to people with compromised immune systems, including those with AIDS, cystic fibrosis, chronic obstructive lung disease and cancer patients undergoing chemotherapy or… – |
http://www.healasthma.com
|


